Methodological challenges in calculation of daily average consumption (DACON) for GLP-1 receptor agonist injectables from claims data

May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1472
https://www.valueinhealthjournal.com/article/S1098-3015(14)01523-X/fulltext
Section Title : Diabetes/Endocrine Disorders I
Section Order : 947
First Page : A252
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01523-X&doi=10.1016/j.jval.2014.03.1472
HEOR Topics :
Tags :
Regions :